Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Hemminki · SciRah

Researcher profile · Semantic Scholar

A. Hemminki

Share profile

A. Hemminki — researcher profile on SciRah

h-index: 73
Works: 473
Citations: 26K

Most-cited papers

Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
L. Galluzzi, I. Vitale, S. Warren, S. Adjemian +50 more
2020Journal for ImmunoTherapy of Cancer993 citations Open access
Semantic Scholar
Familial Risks and Proportions Describing Population Landscape of Familial Cancer
K. Hemminki, K. Sundquist, J. Sundquist, A. Försti +2 more
2021Cancers50 citations Open access
Semantic Scholar
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer
James H. A. Clubb, T. Kudling, C. Heiniö, S. Basnet +13 more
2022Frontiers in Immunology45 citations Open access
Semantic Scholar
Cytokine-Coding Oncolytic Adenovirus TILT-123 Is Safe, Selective, and Effective as a Single Agent and in Combination with Immune Checkpoint Inhibitor Anti-PD-1
R. Havunen, R. Kalliokoski, M. Siurala, S. Sorsa +4 more
2021Cells39 citations Open access
Semantic Scholar
Oncolytic Adenovirus Coding for a Variant Interleukin 2 (vIL-2) Cytokine Re-Programs the Tumor Microenvironment and Confers Enhanced Tumor Control
D. Quixabeira, Sadia Zafar, J. Santos, V. Cervera-Carrascón +6 more
2021Frontiers in Immunology36 citations Open access
Semantic Scholar
Viral Vectors Expressing Interleukin 2 for Cancer Immunotherapy
Hong-bin Wang, Mia C. Borlongan, A. Hemminki, S. Basnet +4 more
2023Human Gene Therapy31 citations Open access
Semantic Scholar
Systemic Delivery of Oncolytic Adenovirus to Tumors Using Tumor-Infiltrating Lymphocytes as Carriers
J. Santos, C. Heiniö, D. Quixabeira, Sadia Zafar +6 more
2021Cells31 citations Open access
Semantic Scholar
Survival in colon and rectal cancers in Finland and Sweden through 50 years
K. Hemminki, A. Försti, A. Hemminki
2021BMJ Open Gastroenterology30 citations Open access
Semantic Scholar
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition
V. Cervera-Carrascón, D. Quixabeira, J. Santos, R. Havunen +14 more
2020Oncoimmunology28 citations Open access
Semantic Scholar
Single intravenous administration of oncolytic adenovirus TILT-123 results in systemic tumor transduction and immune response in patients with advanced solid tumors
E. Jirovec, D. Quixabeira, James H. A. Clubb, S. Pakola +19 more
2024Journal of experimental & clinical cancer research : CR27 citations Open access
Semantic Scholar
Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression
T. Kudling, J. Clubb, D. Quixabeira, J. Santos +20 more
2022Oncoimmunology27 citations Open access
Semantic Scholar
Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden
K. Hemminki, A. Försti, Tianhui Chen, A. Hemminki
2021BMC Cancer27 citations Open access
Semantic Scholar
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine
S. Basnet, M. van der Heijden, D. C. Quixabeira, E. Jirovec +12 more
2024Molecular Therapy25 citations Open access
Semantic Scholar
Safety, Efficacy, and Biological Data of T-Cell–Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial
S. Pakola, Katriina J Peltola, J. Clubb, E. Jirovec +18 more
2024Clinical Cancer Research24 citations Open access
Semantic Scholar
Survival trends in solid cancers in the Nordic countries through 50 years.
Janne Hemminki, A. Försti, A. Hemminki, K. Hemminki
2022European Journal of Cancer23 citations Open access
Semantic Scholar
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers
K. Hemminki, K. Sundquist, J. Sundquist, A. Försti +3 more
2022International Journal of Cancer22 citations Open access
Semantic Scholar
Adenovirus Armed With TNFa and IL2 Added to aPD-1 Regimen Mediates Antitumor Efficacy in Tumors Refractory to aPD-1
V. Cervera-Carrascón, D. Quixabeira, J. Santos, R. Havunen +11 more
2021Frontiers in Immunology22 citations Open access
Semantic Scholar
Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs
Elin M. V. Forsberg, R. Riise, Sara Saellström, J. Karlsson +8 more
2022bioRxiv21 citations Open access
Semantic Scholar
Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer
T. Kudling, J. Clubb, S. Pakola, D. Quixabeira +17 more
2023Oncoimmunology20 citations Open access
Semantic Scholar
Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment
K. Hemminki, A. Kanerva, A. Försti, A. Hemminki
2022BMC Cancer19 citations Open access
Semantic Scholar
Oncolytic adenovirus decreases the proportion of TIM-3+ subset of tumor-infiltrating CD8+ T cells with correlation to improved survival in patients with cancer
Ilkka Liikanen, S. Basnet, D. Quixabeira, Kristian Taipale +8 more
2022Journal for ImmunoTherapy of Cancer19 citations Open access
Semantic Scholar
Second Primary Cancers After Gastric Cancer, and Gastric Cancer as Second Primary Cancer
G. Zheng, K. Sundquist, J. Sundquist, Tianhui Chen +3 more
2021Clinical Epidemiology19 citations Open access
Semantic Scholar
Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden
K. Hemminki, A. Försti, A. Hemminki, B. Ljungberg +1 more
2021PLoS ONE18 citations Open access
Semantic Scholar
Survival in melanoma in the nordic countries into the era of targeted and immunological therapies
Filip Tichánek, A. Försti, A. Hemminki, O. Hemminki +1 more
2023European Journal of Cancer16 citations Open access
Semantic Scholar
Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers
C. Heiniö, J. Clubb, T. Kudling, D. Quixabeira +7 more
2022Diseases16 citations Open access
Semantic Scholar
Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1
D. Quixabeira, V. Cervera-Carrascón, J. Santos, James H. A. Clubb +8 more
2022Oncoimmunology15 citations Open access
Semantic Scholar
Long‐term survival trends in solid cancers in the Nordic countries marking timing of improvements
K. Hemminki, A. Försti, V. Liska, A. Kanerva +2 more
2022International Journal of Cancer15 citations Open access
Semantic Scholar
Long-term survival trends for primary liver and pancreatic cancers in the Nordic countries
K. Hemminki, A. Försti, O. Hemminki, V. Liska +1 more
2022JHEP Reports15 citations Open access
Semantic Scholar
Treatment of Advanced Renal Cell Carcinoma: Immunotherapies Have Demonstrated Overall Survival Benefits While Targeted Therapies Have Not
O. Hemminki, N. Perlis, J. Bjorklund, A. Finelli +2 more
2020European Urology Open Science15 citations Open access
Semantic Scholar
Survival in Colon, Rectal and Small Intestinal Cancers in the Nordic Countries through a Half Century
Filip Tichánek, A. Försti, V. Liska, A. Hemminki +1 more
2023Cancers13 citations Open access
Semantic Scholar
Boosting cytotoxicity of adoptive allogeneic NK cell therapy with an oncolytic adenovirus encoding a human vIL-2 cytokine for the treatment of human ovarian cancer
D. Quixabeira, S. Pakola, E. Jirovec, R. Havunen +14 more
2023Cancer Gene Therapy13 citations Open access
Semantic Scholar
Incidence trends in lung and bladder cancers in the Nordic Countries before and after the smoking epidemic
K. Hemminki, A. Försti, A. Hemminki, B. Ljungberg +1 more
2021European Journal of Cancer Prevention13 citations Open access
Semantic Scholar
Improving the cytotoxic response of tumor-infiltrating lymphocytes towards advanced stage ovarian cancer with an oncolytic adenovirus expressing a human vIL-2 cytokine
D. Quixabeira, E. Jirovec, S. Pakola, R. Havunen +13 more
2023Cancer Gene Therapy12 citations Open access
Semantic Scholar
Long‐term incidence and survival trends in cancer of the gallbladder and extrahepatic bile ducts in Denmark, Finland, Norway and Sweden with etiological implications related to Thorotrast
K. Hemminki, A. Försti, O. Hemminki, V. Liska +1 more
2022International Journal of Cancer12 citations Open access
Semantic Scholar
Oncolytic adenovirus coding for bispecific T cell engager against human MUC-1 potentiates T cell response against solid tumors
S. Basnet, J. Santos, D. Quixabeira, James H. A. Clubb +11 more
2022Molecular Therapy: Oncolytics12 citations Open access
Semantic Scholar
Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up
Sara Saellstrom, Arian Sadeghi, E. Eriksson, T. Segall +6 more
2021Frontiers in Veterinary Science11 citations Open access
Semantic Scholar
Survival in Lung Cancer in the Nordic Countries Through A Half Century
Filip Tichánek, A. Försti, O. Hemminki, A. Hemminki +1 more
2023Clinical Epidemiology10 citations Open access
Semantic Scholar
Familial Risks for Liver, Gallbladder and Bile Duct Cancers and for Their Risk Factors in Sweden, a Low-Incidence Country
K. Hemminki, K. Sundquist, J. Sundquist, A. Försti +3 more
2022Cancers10 citations Open access
Semantic Scholar
Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma
I. Milenova, Marta López González, D. Quixabeira, J. Santos +6 more
2021Human Gene Therapy10 citations Open access
Semantic Scholar
Survival in oral and pharyngeal cancers is catching up with laryngeal cancer in the NORDIC countries through a half century
F. Zitricky, Anni Koskinen, O. Hemminki, A. Försti +2 more
2024Cancer Medicine9 citations Open access
Semantic Scholar
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting
James H. A. Clubb, T. Kudling, M. Girych, L. Haybout +23 more
2023Frontiers in Immunology9 citations Open access
Semantic Scholar
Survival, Incidence, and Mortality Trends in Female Cancers in the Nordic Countries
Filip Tichánek, A. Försti, O. Hemminki, A. Hemminki +1 more
2023Obstetrics and Gynecology International9 citations Open access
Semantic Scholar
Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers
G. Zheng, K. Sundquist, J. Sundquist, Tianhui Chen +4 more
2021Clinical Epidemiology9 citations Open access
Semantic Scholar
Incidence trends in bladder and lung cancers between Denmark, Finland and Sweden may implicate oral tobacco (snuff/snus) as a possible risk factor
K. Hemminki, A. Försti, A. Hemminki, B. Ljungberg +1 more
2021BMC Cancer9 citations Open access
Semantic Scholar
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial
S. Pakola, J. Clubb, T. Kudling, M. van der Heijden +15 more
2025Journal for ImmunoTherapy of Cancer8 citations Open access
Semantic Scholar
An oncolytic adenovirus coding for a variant interleukin 2 cytokine improves response to chemotherapy through enhancement of effector lymphocyte cytotoxicity, fibroblast compartment modulation and mitotic slippage
S. Pakola, D. Quixabeira, T. Kudling, James H. A. Clubb +11 more
2023Frontiers in Immunology8 citations Open access
Semantic Scholar
Survival in gastric and esophageal cancers in the Nordic countries through a half century
K. Hemminki, Filip Tichánek, A. Försti, O. Hemminki +1 more
2023Cancer Medicine8 citations Open access
Semantic Scholar
Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years.
Filip Tichánek, A. Försti, O. Hemminki, A. Hemminki +1 more
2023Cancer Epidemiology7 citations Open access
Semantic Scholar
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
K. Hemminki, K. Sundquist, J. Sundquist, A. Försti +3 more
2023Cancers7 citations Open access
Semantic Scholar
Conditional survival in breast cancer up to 10 years in the Nordic countries
F. Zitricky, A. Försti, A. Hemminki, K. Hemminki
2023Cancer Medicine7 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Försti×24
Invite
A. Försti — researcher profile on SciRah
K. Hemminki×21
Invite
K. Hemminki — researcher profile on SciRah
D. Quixabeira×19
Invite
D. Quixabeira — researcher profile on SciRah
O. Hemminki×19
Invite
O. Hemminki — researcher profile on SciRah

×18

Invite

J. Santos — researcher profile on SciRah

V. Cervera-Carrascón×18

Invite

V. Cervera-Carrascón — researcher profile on SciRah

Invite

R. Havunen — researcher profile on SciRah

Invite

A. Kanerva — researcher profile on SciRah

Invite

T. Kudling — researcher profile on SciRah

Invite

S. Pakola — researcher profile on SciRah

Invite

S. Basnet — researcher profile on SciRah

Invite

C. Heiniö — researcher profile on SciRah